Table 2.
Associated adverse events to convalescent plasma in different epidemics.
| Country | Viral etiology | Adverse events | References |
|---|---|---|---|
| China | COVID-19 | None | [47] |
| China | COVID-19 | None | [48] |
| China | COVID-19 | Self-limited facial erythema in 2/10 patients. No major adverse events. | [49] |
| China | COVID-19 | None | [50] |
| South Korea | COVID-19 | None | [51] |
| China | SARS-CoV | None | [52] |
| China | SARS-CoV | None | [53] |
| China | SARS-CoV | None | [54] |
| Taiwan | SARS-CoV | None | [55] |
| China | SARS-CoV | None | [56] |
| China | SARS-CoV | None | [57] |
| China | SARS-CoV | None | [58] |
| South Korea | MERS-CoV | None | [59] |
| Guinea | Ebola | Nausea, skin erythema, fever. No major adverse events. | [60] |
| China | Influenza A (H1N1) | None | [61] |
| China | Influenza A (H1N1) | None | [62] |
| China | Influenza A (H1N1) | None | [63] |
| China | Influenza A (H1N1) | None | [64] |